TY - JOUR
T1 - Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal submucosal tumors
AU - Yamao, Kenji
AU - Sawaki, Akira
AU - Salem, Ahmed
PY - 2004
Y1 - 2004
N2 - Gastrointestinal submucosal tumors (SMT) detected by barium meal study or endoscopy include various kinds of diseases and various degrees of malignancy. Endoscopic ultrasonography (EUS) can provide useful information about the differentiation of intra- and extra-wall lesions, location and originating layer, presumption of their histological nature, measurement of the actual size of the lesion, and the possibility of differentiating between a benign and a malignant lesion. However, EUS alone does not reveal the complete pathology. EUS fine-needle aspiration biopsy (EUS-FNAB) has been reported to be a useful tissue sampling method for pancreatic mass lesions, lymph nodes swelling, posterior mediastinal masses and also gastrointestinal submucosal tumors. The EUS-FNAB procedure is effective not only for the differential diagnosis of benignancy and malignancy, but also for the specific histopathological nature of gastrointestinal SMT using immunohistochemical staining. When used with MIB-1 (Ki-67) staining, and gene analysis in case of gastrointestinal stromal tumor, EUS-FNAB may indicate its prognosis and influence decisions regarding therapeutic strategy. Thus, EUS-FNAB is an indispensable procedure in the diagnosis of SMT.
AB - Gastrointestinal submucosal tumors (SMT) detected by barium meal study or endoscopy include various kinds of diseases and various degrees of malignancy. Endoscopic ultrasonography (EUS) can provide useful information about the differentiation of intra- and extra-wall lesions, location and originating layer, presumption of their histological nature, measurement of the actual size of the lesion, and the possibility of differentiating between a benign and a malignant lesion. However, EUS alone does not reveal the complete pathology. EUS fine-needle aspiration biopsy (EUS-FNAB) has been reported to be a useful tissue sampling method for pancreatic mass lesions, lymph nodes swelling, posterior mediastinal masses and also gastrointestinal submucosal tumors. The EUS-FNAB procedure is effective not only for the differential diagnosis of benignancy and malignancy, but also for the specific histopathological nature of gastrointestinal SMT using immunohistochemical staining. When used with MIB-1 (Ki-67) staining, and gene analysis in case of gastrointestinal stromal tumor, EUS-FNAB may indicate its prognosis and influence decisions regarding therapeutic strategy. Thus, EUS-FNAB is an indispensable procedure in the diagnosis of SMT.
UR - http://www.scopus.com/inward/record.url?scp=10044224342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10044224342&partnerID=8YFLogxK
U2 - 10.1111/j.1443-1661.2004.00438.x
DO - 10.1111/j.1443-1661.2004.00438.x
M3 - Article
AN - SCOPUS:10044224342
SN - 0915-5635
VL - 16
SP - S197-S200
JO - Digestive Endoscopy
JF - Digestive Endoscopy
IS - SUPPL. 2
ER -